These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 1679408)
21. [Analysis of oncogenes and tumor suppressor genes]. Sekiya T Tanpakushitsu Kakusan Koso; 1993 Feb; 38(3):314-20. PubMed ID: 8488265 [No Abstract] [Full Text] [Related]
22. MicroRNAs in human cancer: from research to therapy. Negrini M; Ferracin M; Sabbioni S; Croce CM J Cell Sci; 2007 Jun; 120(Pt 11):1833-40. PubMed ID: 17515481 [TBL] [Abstract][Full Text] [Related]
24. [Gene therapy in oncology: applications to lung cancer]. Chapiro J; Palma MD; Mignot L; Lemonnier MP; Beaumelou E; Coulet F; Misset JL; Jasmin C Rev Mal Respir; 1996 Oct; 13(5):467-76. PubMed ID: 8999473 [TBL] [Abstract][Full Text] [Related]
25. [Tumor suppressor gene: implication in the clinical medicine]. Takai S; Tanaka N; Shin E; Yamamoto M Gan To Kagaku Ryoho; 1990 Jul; 17(7):1281-6. PubMed ID: 1973346 [TBL] [Abstract][Full Text] [Related]
26. Current strategies in cancer gene therapy. El-Aneed A Eur J Pharmacol; 2004 Sep; 498(1-3):1-8. PubMed ID: 15363969 [TBL] [Abstract][Full Text] [Related]
27. Systematic multiplex polymerase chain reaction and reverse transcription-polymerase chain reaction analyses of changes in copy number and expression of proto-oncogenes and tumor suppressor genes in cancer tissues and cell lines. Yamamoto M; Metoki R; Yamamoto F Electrophoresis; 2004 Oct; 25(20):3349-56. PubMed ID: 15490458 [TBL] [Abstract][Full Text] [Related]
29. [Use of recombinant DNA technique in circulatory system diseases. A short outline of recombinant DNA methods]. Buraczyńska M; Hanzlik J Pol Merkur Lekarski; 1996 Aug; 1(2):139-42. PubMed ID: 9156915 [No Abstract] [Full Text] [Related]
33. [Chromosome abnormalities and tumor suppressor gene in childhood cancer]. Hayashi Y Gan To Kagaku Ryoho; 1990 Dec; 17(12):2327-32. PubMed ID: 1979726 [TBL] [Abstract][Full Text] [Related]
34. [Detection of genetic alterations in human cancer]. Shimizu K Seikagaku; 1997 May; 69(5):311-23. PubMed ID: 9214842 [No Abstract] [Full Text] [Related]
35. [Oncogenes and tumor suppressor genes of human breast cancer]. Takita K; Sato T; Nakamura Y Tanpakushitsu Kakusan Koso; 1993 Feb; 38(3):305-13. PubMed ID: 8098157 [No Abstract] [Full Text] [Related]
36. [Genes of hereditary diseases that predispose to tumors]. Thomas G Bull Cancer; 1988; 75(9):871-8. PubMed ID: 2905179 [TBL] [Abstract][Full Text] [Related]
37. Anti-oncogene and tumor suppressor gene therapy--examples from a lung cancer animal model. Zhang WW; Roth JA In Vivo; 1994; 8(5):755-69. PubMed ID: 7727723 [TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of oncogenes and tumor suppressor genes in human malignancy. Spandidos DA; Liloglou T; Field JK Stem Cells; 1993 May; 11(3):194-8. PubMed ID: 8318905 [TBL] [Abstract][Full Text] [Related]
39. [Genetic background in carcinogenesis]. Suzuki T; Kanamaru R Gan To Kagaku Ryoho; 1999 Nov; 26(13):1971-9. PubMed ID: 10584560 [TBL] [Abstract][Full Text] [Related]
40. [Present status of gene therapy in cancer]. Yoshida T Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):351-5. PubMed ID: 8690993 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]